Dexmethylphenidate
Back to searchMolecule Structure
Scientific Name
Dexmethylphenidate
Description of the Drug
Dexmethylphenidate is a norepinephrine-dopamine reuptake inhibitor used in the treatment of ADHD in conjunction with other therapies.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB06701
http://www.drugbank.ca/drugs/DB06701
Brand Name(s)
Not Available
Company Owner(s)
Lannett Co Inc, Impax Laboratories Inc, Novartis Pharmaceuticals Corp, Mylan Pharmaceuticals Inc A Viatris Co, Par Pharmaceutical Inc, Uspharma Ltd, Mylan Pharmaceuticals Inc, Teva Pharmaceuticals Usa, Sun Pharmaceutical Industries Inc, Rhodes Pharmaceuticals Lp
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Norepinephrine transporter | SINGLE PROTEIN | INHIBITOR | CHEMBL222 |
| Dopamine transporter | SINGLE PROTEIN | INHIBITOR | CHEMBL238 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL34326 | ||
| Human Metabolome Database | HMDB0015647 | ||
| DrugBank | DB06701 | ||
| PubChem: Thomson Pharma | 14847270 | 15121721 | |
| PubChem | 154101 | ||
| Nikkaji | J343.157F | ||
| BindingDB | 50062915 | ||
| EPA CompTox Dashboard | DTXSID70893769 | ||
| DrugCentral | 836 | ||
| Brenda | 72091 | 161119 | |
| Guide to Pharmacology | 7554 | ||
| GSRS | c01838fb-a50c-4f19-a3f5-48f0dadf4908 | ||
| rxnorm | DEXMETHYLPHENIDATE HYDROCHLORIDE | DEXMETHYLPHENIDATE | FOCALIN |
| ChEBI | 51860 | ||
| ZINC | ZINC000000896711 |
